Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-Jul-23 4:55 PM View:  | Cyclacel Pharmaceuticals, I... (CYCC) | 30-Jun-23 | Grant | 21,219 | -- | -- | 117% 18.2K to 39.41K | |
| 16-Jun-22 4:11 PM View: | Cyclacel Pharmaceuticals, I... (CYCC) | 14-Jun-22 | Grant | 15,822 | -- | -- | 666% 2.37K to 18.2K | |
| 16-Jul-21 4:02 PM View: | Prothena Corporation plc (PRTA) | 14-Jul-21 | Option Exercise | 11,108 | $11.33 | $125,854.00 | 100% 0 to 11.11K | |
| 16-Jul-21 4:02 PM View: | Prothena Corporation plc (PRTA) | 14-Jul-21 | Planned Option Sale | 11,108 | $55.46 | $616,020.00 | (100%) 11.11K to 0 | |
| 29-Jun-21 6:13 PM View: | Prothena Corporation plc (PRTA) | 25-Jun-21 | Option Exercise | 12,000 | $16.43 | $197,160.00 | 100% 0 to 12.0K | |
| 29-Jun-21 6:13 PM View: | Prothena Corporation plc (PRTA) | 25-Jun-21 | Option Sale | 12,000 | $47.73 | $572,819.00 | (100%) 12.0K to 0 | |
| 17-Jun-21 4:07 PM View: | Cyclacel Pharmaceuticals, I... (CYCC) | 15-Jun-21 | Grant | 2,374 | -- | -- | 100% 0 to 2.37K | |
| 13-Mar-18 6:01 PM View: | Oncothyreon Inc (CASC) | 09-Mar-18 | Disposition (change in control) | 60,185 | -- | -- | (100%) 60.19K to 0 | |
| 29-Sep-17 5:15 PM View: | Prothena Corporation plc (PRTA) | 28-Sep-17 | Option Exercise | 900 | $6.65 | $5,985.00 | 100% 0 to 0.9K | |
| 29-Sep-17 5:15 PM View: | Prothena Corporation plc (PRTA) | 28-Sep-17 | Market Option Sale | 900 | $70.00 | $63,000.00 | (100%) 0.9K to 0 | 81% |
| 26-Sep-17 5:19 PM View: | Oncothyreon Inc (CASC) | 24-Sep-17 | Payment of Exercise | 594 | $3.94 | $2,340.36 | (< 1%) 60.78K to 60.19K | (156%) |
| 26-Sep-17 5:19 PM View: | Oncothyreon Inc (CASC) | 24-Sep-17 | Option Exercise | 2,375 | -- | -- | 4% 58.4K to 60.78K | |
| 19-Jul-17 4:10 PM View: | Prothena Corporation plc (PRTA) | 17-Jul-17 | Option Exercise | 5,000 | $6.65 | $33,250.00 | 100% 0 to 5.0K | |
| 19-Jul-17 4:10 PM View: | Prothena Corporation plc (PRTA) | 17-Jul-17 | Market Option Sale (Planned) | 5,000 | $66.13 | $330,670.00 | (100%) 5.0K to 0 | 80% |
| 27-Jun-17 5:39 PM View: | Oncothyreon Inc (CASC) | 24-Jun-17 | Payment of Exercise | 2,265 | $3.78 | $8,561.70 | (4%) 60.67K to 58.4K | (167%) |
| 27-Jun-17 5:39 PM View: | Oncothyreon Inc (CASC) | 24-Jun-17 | Option Exercise | 9,058 | -- | -- | 18% 51.61K to 60.67K | |
| 13-Jun-17 4:39 PM View: | Oncothyreon Inc (CASC) | 12-Jun-17 | Payment of Exercise | 537 | $3.34 | $1,793.58 | (1%) 52.15K to 51.61K | (202%) |
| 13-Jun-17 4:39 PM View: | Oncothyreon Inc (CASC) | 12-Jun-17 | Option Exercise | 2,148 | -- | -- | 4% 50.0K to 52.15K | |
| 01-Mar-17 4:05 PM View: | Prothena Corporation plc (PRTA) | 27-Feb-17 | Option Exercise | 5,989 | $6.65 | $39,826.90 | 100% 0 to 5.99K | |
| 01-Mar-17 4:05 PM View: | Prothena Corporation plc (PRTA) | 27-Feb-17 | Market Option Sale | 5,989 | $57.16 | $342,350.00 | (100%) 5.99K to 0 | 77% |
| 22-Feb-17 5:05 PM View: | Prothena Corporation plc (PRTA) | 17-Feb-17 | Option Exercise | 4,011 | $6.65 | $26,673.20 | 100% 0 to 4.01K | |
| 22-Feb-17 5:05 PM View: | Prothena Corporation plc (PRTA) | 17-Feb-17 | Market Option Sale | 4,011 | $57.06 | $228,880.00 | (100%) 4.01K to 0 | 77% |
| 01-Feb-17 4:38 PM View: | Oncothyreon Inc (CASC) | 30-Jan-17 | Market Purchase | 25,324 | $4.11 | $103,973.00 | 103% 24.68K to 50.0K | 145% |
| 10-Feb-17 10:00 PM View: | Oncothyreon Inc (CASC) | 06-Jun-16 | Payment of Exercise | 681 | $7.38 | $5,025.78 | (1%) 50.68K to 50.0K | |
| 10-Feb-17 10:00 PM View: | Oncothyreon Inc (CASC) | 06-Jun-16 | Option Exercise | 2,723 | -- | -- | 6% 47.96K to 50.68K | |
| 01-Dec-15 4:05 PM View: | Prothena Corporation plc (PRTA) | 27-Nov-15 | Option Exercise | 5,000 | $6.65 | $33,250.00 | 100% 0 to 5.0K | |
| 01-Dec-15 4:05 PM View: | Prothena Corporation plc (PRTA) | 27-Nov-15 | Market Option Sale | 5,000 | $75.00 | $375,000.00 | (100%) 5.0K to 0 | 84% |
| 30-Oct-15 4:05 PM View: | Prothena Corporation plc (PRTA) | 29-Oct-15 | Option Exercise | 5,000 | $6.65 | $33,250.00 | 100% 0 to 5.0K | |
| 30-Oct-15 4:05 PM View: | Prothena Corporation plc (PRTA) | 29-Oct-15 | Market Option Sale | 5,000 | $55.00 | $275,000.00 | (100%) 5.0K to 0 | 78% |
| 07-Aug-15 5:37 PM View: | Prothena Corporation plc (PRTA) | 07-Aug-15 | Option Exercise | 10,000 | $6.41 | $64,100.00 | 100% 0 to 10.0K | |
| 07-Aug-15 5:37 PM View: | Prothena Corporation plc (PRTA) | 07-Aug-15 | Market Option Sale | 10,000 | $62.93 | $629,298.00 | (100%) 10.0K to 0 | 81% |
| 16-Jun-15 4:53 PM View: | Oncothyreon Inc (CASC) | 13-Jun-14 | Payment of Exercise | 4,011 | $3.88 | $15,562.70 | (3%) 139.82K to 135.81K | |
| 16-Jun-15 4:53 PM View: | Oncothyreon Inc (CASC) | 13-Jun-14 | Option Exercise | 16,042 | -- | -- | 13% 123.78K to 139.82K | |
| 10-Jun-14 7:39 PM View: | Oncothyreon Inc (CASC) | 07-Jun-14 | Payment of Exercise | 2,044 | $3.06 | $6,254.64 | (2%) 125.82K to 123.78K | 45% |
| 12-Mar-14 5:02 PM View: | Oncothyreon Inc (CASC) | 11-Mar-14 | Payment of Exercise | 4,838 | $3.65 | $17,658.70 | (4%) 130.66K to 125.82K | 54% |
| 12-Mar-14 5:02 PM View: | Oncothyreon Inc (CASC) | 11-Mar-14 | Option Exercise | 19,352 | -- | -- | 17% 111.31K to 130.66K | |
| 11-Jun-13 5:02 PM View: | Oncothyreon Inc (CASC) | 09-Jun-13 | Payment of Exercise | 1,135 | $1.86 | $2,111.10 | (1%) 112.44K to 111.31K | 10% |
| 02-Jul-12 5:46 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 29-Jun-12 | Market Purchase | 100,000 | $0.75 | $74,930.00 | 98% 102.43K to 202.43K | (100%) |
| 02-Jul-12 5:46 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 29-Jun-12 | Market Purchase | 100,000 | $0.75 | $74,930.00 | 49% 202.43K to 302.43K | (100%) |
| 08-Jun-12 3:58 PM View: | Oncothyreon Inc (CASC) | 07-Jun-12 | Grant | 8,174 | $3.67 | $29,998.60 | 8% 104.27K to 112.44K | (54%) |
| 05-Jun-12 6:33 PM View: | Oncothyreon Inc (CASC) | 03-Jun-12 | Payment of Exercise | 2,021 | $3.51 | $7,093.71 | (2%) 106.29K to 104.27K | 52% |
| 04-May-12 7:06 PM View: | Oncothyreon Inc (CASC) | 03-May-12 | Payment of Exercise | 247 | $4.15 | $1,025.05 | (< 1%) 106.53K to 106.29K | 60% |
| 04-May-12 7:06 PM View: | Oncothyreon Inc (CASC) | 03-May-12 | Option Exercise | 989 | -- | -- | < 1% 105.55K to 106.53K | |
| 03-Jan-12 3:18 PM View: | Oncothyreon Inc (CASC) | 31-Dec-11 | Payment of Exercise | 597 | $7.58 | $4,525.26 | (< 1%) 106.14K to 105.55K | 78% |
| 03-Jan-12 3:18 PM View: | Oncothyreon Inc (CASC) | 31-Dec-11 | Option Exercise | 2,388 | -- | -- | 2% 103.75K to 106.14K | |
| 07-Dec-11 6:40 PM View: | Oncothyreon Inc (CASC) | 04-Dec-11 | Payment of Exercise | 1,546 | $6.86 | $10,605.60 | (1%) 105.3K to 103.75K | 76% |
| 05-Dec-11 7:21 PM View: | Oncothyreon Inc (CASC) | 01-Dec-11 | Payment of Exercise | 6,250 | $6.92 | $43,250.00 | (6%) 111.55K to 105.3K | 76% |
| 05-Dec-11 7:21 PM View: | Oncothyreon Inc (CASC) | 01-Dec-11 | Option Exercise | 25,000 | -- | -- | 29% 86.55K to 111.55K | |
| 18-Nov-11 9:33 PM View: | Oncothyreon Inc (CASC) | 18-Nov-11 | Disposition | 12,500 | $6.36 | $79,500.00 | (13%) 99.05K to 86.55K | (14%) |
| 12-Oct-11 11:40 AM View: | Oncothyreon Inc (CASC) | 10-Oct-11 | Option Exercise | 50,000 | -- | -- | 102% 49.05K to 99.05K |